| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/16/1994 | US5338834 Ultrapure human interleukin-6 |
| 08/16/1994 | US5338833 Carboxy terminal IL-6 muteins |
| 08/16/1994 | US5338830 Cyclic peptides having diuretic and vasodilation activity |
| 08/16/1994 | US5338829 Peptides derived from human immunodeficiency virus-1 GP160 |
| 08/16/1994 | US5338727 Therapeutic agent for the prevention or treatment of adult respiratory distress syndrome |
| 08/16/1994 | US5338726 Endothelin converting enzyme inhibitors |
| 08/16/1994 | US5338725 Anti-aggregatory agents for platelets |
| 08/16/1994 | US5338724 Antimicrobial proteins, compositions containing same and uses thereof |
| 08/16/1994 | US5338683 Genetic engineering, vaccines |
| 08/16/1994 | US5338677 Heparinase free of an anticoagulant component from flavobacterium Heparinum |
| 08/16/1994 | US5338668 Opioid peptides derived from wheat proteins |
| 08/16/1994 | US5338663 Interferes with formation of specific complex between alpha-antichymotrypsin and beta-protein; hydrolysis of substrate does not occur |
| 08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
| 08/16/1994 | US5338564 Fat substitute compositions including waxes for a reduced laxative effect |
| 08/16/1994 | US5338547 Providing soybean solubles produced from acidic aqueous-extracted hexane-defatted soybenas, diluting with aqueous solution to slurry, separating, diluting again, performing ultrafiltration, drying, administering |
| 08/16/1994 | US5338546 Substituting amino acids; vascular system disorders |
| 08/16/1994 | CA2115631A1 Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them |
| 08/16/1994 | CA2115630A1 Bioactive conjugates of cellulose with amino compounds |
| 08/16/1994 | CA2115532A1 Pseudopeptides having an antiviral action |
| 08/16/1994 | CA1331499C Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments |
| 08/16/1994 | CA1331498C Oligopeptides with cyclic proline-analogous amino acids |
| 08/13/1994 | CA2115522A1 Hst-2 mutein, dna coding for the same and preparation thereof |
| 08/11/1994 | DE4404124A1 Mutierte Tumor-Nekrose-Faktor-Proteine Mutant tumor necrosis factor-proteins |
| 08/11/1994 | DE4303744A1 Canine growth hormone |
| 08/11/1994 | DE4303530A1 Pharmaceutical use of an endorphin |
| 08/10/1994 | EP0610078A1 Cytotoxic and antiviral compound |
| 08/10/1994 | EP0610046A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispesific fusion proteins in a mammalian cell |
| 08/10/1994 | EP0609901A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| 08/10/1994 | EP0609739A1 Method of reversing immunosuppression in vaccines |
| 08/10/1994 | EP0609722A1 An in vitro method for detecting the presence of invasive stimuli in mammals |
| 08/10/1994 | EP0609625A1 Inhibitors of HIV protease useful for the treatment of AIDS |
| 08/10/1994 | EP0609471A1 Use of collagen for the treatment of diseased joint processes |
| 08/10/1994 | EP0609359A1 Dimorphism genes in fungi |
| 08/10/1994 | EP0609345A1 Biocompatible implant for the timing of ovulation in mares |
| 08/10/1994 | EP0609293A1 Treatment of haemophilia |
| 08/10/1994 | EP0609280A1 Human il-3 variants |
| 08/10/1994 | EP0609242A1 New thrombin-inhibiting protein isolated from ticks. |
| 08/10/1994 | EP0564561A4 Peptides ketoamides, ketoacids, and ketoesters |
| 08/10/1994 | EP0500800B1 Antihemostatic factor vii peptides |
| 08/10/1994 | EP0424484B1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection |
| 08/10/1994 | EP0302065B1 Pharmaceutical compositions |
| 08/10/1994 | CN1090584A Synthetic polypeptides |
| 08/10/1994 | CN1090510A Interferon tau compositions and methods of use |
| 08/10/1994 | CN1090509A Pharmaceutical composition |
| 08/10/1994 | CN1090508A Physiologically active peptide composition |
| 08/10/1994 | CA2115222A1 Sulfonamide aminomethylene derivatives as immunosuppressants |
| 08/10/1994 | CA2115221A1 Aminomethylene-peptides as immunosuppressants |
| 08/09/1994 | US5336759 Biologically active peptide derived from frog (frog CNP) |
| 08/09/1994 | US5336758 AIDS vaccines |
| 08/09/1994 | US5336757 Antibacterial peptide and methods of use |
| 08/09/1994 | US5336756 Dissolving in propanol allowing to crystallize |
| 08/09/1994 | US5336667 Polypeptides from snake venom inhibiting binding of von Willebrand factor |
| 08/09/1994 | US5336666 Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae |
| 08/09/1994 | US5336618 Monoclonal antibody of the class IgG1, designated 7E3, reacts readily with both normal human and dog blood platelets while fail to react with thrombasthenic human platelets |
| 08/09/1994 | US5336615 Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity |
| 08/09/1994 | US5336610 Adsorption by immobilized HPC-4, a calcium-dependent monoclonal antibody which binds specifically to the epitope in the activation region of the heavy chain |
| 08/09/1994 | US5336603 CD4 adheson variants |
| 08/09/1994 | US5336595 Determining the body fluid concentration of substance P antagonists in arthritis patients |
| 08/09/1994 | US5336495 Does not induce neutralizing antibodies, so it may be repeatedly administered |
| 08/09/1994 | US5336494 Produces antibacterial and bacteriostatic effect in mouth by activation of enzyme system within the coating |
| 08/09/1994 | US5336493 Superoxide dismutase-catalase conjugates |
| 08/09/1994 | US5336492 Bacillus thuringiensis isolates denoted B.T. PS81F, active against lepidopteran pests |
| 08/09/1994 | US5336491 Using Pasteurella haemolytica antigen |
| 08/09/1994 | US5336489 Treatment of allograft rejection with IL-2 receptor-specific cytotoxins |
| 08/09/1994 | US5336488 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
| 08/09/1994 | CA1331419C Peptides with pharmaceutical activity |
| 08/09/1994 | CA1331356C Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
| 08/09/1994 | CA1331355C Immunopotentation |
| 08/09/1994 | CA1331345C Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth |
| 08/06/1994 | WO1994017820A1 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
| 08/06/1994 | CA2126455A1 Liver fluke vaccine and polypeptides useful for same |
| 08/06/1994 | CA2088878A1 Cdnas encoding the gastrin and cck-b receptors |
| 08/04/1994 | WO1994017415A1 Novel anticoagulant cofactor activity |
| 08/04/1994 | WO1994017411A1 Methods and agents for the diagnosis and treatment of rheumatoid arthritis |
| 08/04/1994 | WO1994017197A1 ANTIBODY AGAINST β-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF |
| 08/04/1994 | WO1994017196A1 Detection and treatment of mutations in a cd40 ligand gene |
| 08/04/1994 | WO1994017193A2 Chimeric l- and p-selectin by exchange of domains - uses thereof |
| 08/04/1994 | WO1994017189A2 Protein kinases |
| 08/04/1994 | WO1994017185A1 G-csf analog compositions and methods |
| 08/04/1994 | WO1994017184A1 Modulation of physiological responses of lymphocytes by cd38 or antibodies thereto |
| 08/04/1994 | WO1994017183A1 Agents for the prevention and treatment of lesch-nyhan syndrome |
| 08/04/1994 | WO1994017104A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 08/04/1994 | WO1994017102A1 Human spasmolytic polypeptide in glycosylated form |
| 08/04/1994 | WO1994017101A1 Max-interacting proteins and related molecules and methods |
| 08/04/1994 | WO1994017100A1 Icam-related protein |
| 08/04/1994 | WO1994017099A2 BIOLOGICALLY ACTIVE TGF-β1 AND TGF-β2 PEPTIDES |
| 08/04/1994 | WO1994017097A1 Synthetic fibronectin fragments as inhibitors of retroviral infections |
| 08/04/1994 | WO1994017096A1 Peptides having anti-hiv activity |
| 08/04/1994 | WO1994017095A1 Analogs of receptor tyrosine activation motifs and therapeutic uses thereof |
| 08/04/1994 | WO1994017087A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | WO1994017055A1 Antiviral naphthoquinone compounds, compositions and uses thereof |
| 08/04/1994 | WO1994017035A1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same |
| 08/04/1994 | WO1994016756A1 Intrapulmonary delivery of hormones |
| 08/04/1994 | WO1994016741A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | WO1994016740A1 The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury |
| 08/04/1994 | WO1994016738A1 Antisense polynucleotide inhibition of human growth factor-sensitive cancer cells |
| 08/04/1994 | WO1994016737A1 Compositions and methods for delivery of genetic material |
| 08/04/1994 | WO1994016730A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | WO1994016729A1 Targeted nitric oxide pathway or nitric oxide synthase modulation |
| 08/04/1994 | WO1994016728A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |